Announcements

Date	Title
10 Oct 24, 10:25	Mydecine Innovations Group Inc - Suspension of Trading	View
22 Aug 24, 12:10	Mydecine Innovations Group Inc - MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM FINANCIAL STATEMENTS	View
08 Jul 24, 07:00	Mydecine Innovations Group Inc - Annual and Q1 Financial Statements	View
14 Jun 24, 07:00	Mydecine Innovations Group Inc - Doc re: Bl-Weekly Status Report	View
03 Jun 24, 07:00	Mydecine Innovations Group Inc - Bl-Weekly Status Report	View
17 May 24, 07:00	Mydecine Innovations Group Inc - Mydecine Provides Bl-Weekly Status Report	View
03 May 24, 09:36	Mydecine Innovations Group Inc - Mydecine applies for management cease trade order	View
03 May 24, 07:10	Mydecine Innovations Group Inc - Management cease trade order	View
03 May 24, 07:00	Mydecine Innovations Group Inc - Restructuring transactions and annual general and special meeting	View
30 Apr 24, 17:29	Mydecine Innovations Group Inc - Total Voting Rights	View
16 Apr 24, 07:00	Mydecine Innovations Group Inc - Closing of Share for Debt Settlement	View
09 Apr 24, 07:00	Mydecine Innovations Group Inc - SHARE FOR DEBT SETTLEMENT	View
28 Mar 24, 07:10	Mydecine Innovations Group Inc - Total Voting Rights	View
28 Mar 24, 07:00	Mydecine Innovations Group Inc - Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement	View
21 Mar 24, 07:00	Mydecine Innovations Group Inc - Share for Debt Settlement	View
01 Mar 24, 09:01	Mydecine Innovations Group Inc - Total Voting Rights	View
23 Feb 24, 07:00	Mydecine Innovations Group Inc - Closing of Share for Debt Settlement	View
08 Feb 24, 07:00	Mydecine Innovations Group Inc - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	View
02 Feb 24, 07:00	Mydecine Innovations Group Inc - Mydecine Innovations Group Announces Director Resignation	View
18 Dec 23, 07:00	Mydecine Innovations Group Inc - Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	View